Recent Articles from Investor Brand Network

A recent federal report sheds light on how Americans use cannabis, highlighting clear differences in consumption habits between men and women. Smoking continues to be the go-to method for most users, but men are far more likely to choose this route than women. On the other hand, women lean more toward edibles, infused drinks, and products applied to the skin like creams and patches.

MoneyShow, a leading producer of live and online financial conferences for investors, traders, and financial advisors, has announced the upcoming “ Mid-Year Portfolio Review ” on June 17-18, 2025. “The year started on a promising note. But sweeping tariff measures, stubborn inflation, and persistent geopolitical stand-offs have caused considerable turmoil in the financial markets,” said MoneyShow’s Editor-in-Chief Mike Larson. “Our exceptional lineup of speakers will provide in-depth context to these market moves, as well as share highly actionable strategies to optimize portfolios for the remainder of 2025.”

Massimo Group (NASDAQ: MAMO) is entering a new growth phase with the launch of a comprehensive digital retail platform. This move is designed to simplify the purchasing process for its UTVs, ATVs, and mini-bikes, while expanding the company’s national sales footprint. “The platform enables customers to complete transactions online, including financing, titling, and checkout, providing a fully digital experience,” reads a recent article discussing the launch. “Massimo expects this shift to unlock greater scalability, reduce sales friction, and drive a significant increase in annual revenue.”

Adageis, a forward-thinking healthcare technology company, has a comprehensive suite of AI-powered solutions aimed at providers shifting from fee-for-service to value-based care. “At the core of the company’s offering is its ProActive Care Platform, which combines predictive analytics with real-time data integration to improve both clinical and financial outcomes,” reads a recent article. “The platform’s Patented Risk Engine (‘PRE’) enables users to forecast revenue based on quality performance metrics and patient care patterns. For providers managing contracts that tie compensation to outcomes, these insights are increasingly important.”

In the last year, Native American tribes have played an increasingly important role in the legal cannabis industry across the U.S.

Vivakor (NASDAQ: VIVK) announced that its Board of Directors has approved a special dividend to be paid in shares of Adapti, Inc., of which Vivakor holds a 13.5% stake. Excluding shares held by its CEO and CFO—who are waiving their rights to participate—eligible shareholders will receive approximately 0.0079 Adapti shares per Vivakor share, a distribution currently valued at $815,000. The record date will be announced in the coming weeks. Adapti, formerly Scepter Holdings, markets products using its AdaptAI platform and became an SEC-reporting company in 2024.

Recent figures released by the Bureau of Ocean Energy Management and the U.S. Energy Information Administration estimate considerable increases in offshore oil production over the next few years. These forecasts reflect growing optimism within the industry and point to a strong future for American offshore energy development.

Hydrogen fuel cell electric vehicles may not have caught on like battery electric vehicles (BEVs), but they may still have a future in transport. While BEVs use charged battery packs, hydrogen fuel cell EVs generate electricity through a chemical reaction between hydrogen and oxygen. The only byproducts are water vapor and warm air, making them a zero-emission alternative to gas-powered cars.

A recently conducted study by a team at Karolinska Institutet in Sweden has established a link between a diagnosis of autism spectrum disorder (ASD) to a heightened risk of Parkinson’s disease (PD). The research appeared in the journal JAMA Neurology . The research team believes the two conditions may share a number of underlying biological mechanisms.

As someone who lost her mobility after a spinal stroke, Caroline Laubach uses a wheelchair full-time. But when she steps into the new AI-powered exoskeleton developed by Wandercraft, she experiences a freedom that goes beyond walking. It enables her to maintain eye contact with others, engage in more natural interactions, and experience a greater sense of inclusion in her daily life.

FingerMotion (NASDAQ: FNGR) reported fiscal year 2025 revenue of $35.61 million, down 0.5% year over year, as gains in SMS & MMS were offset by declines in other segments. SMS & MMS revenue surged 206% to $8.17 million, while the Telecommunications Products & Services business fell 17%. Gross profit dropped 28% to $2.76 million, and the company posted a net loss of $5.11 million, a 34% increase from FY 2024. Initial revenue contributions from the DaGe and C2 platforms signaled progress in platform diversification, a key element of the company’s growth strategy moving forward.

Heavy metal resource developer ESGold (CSE: ESAU) (OTCQB: ESAUF) is taking a “ tangible step ” toward production anticipated to begin later this year in its recovery operation at a historic gold and silver resource named Montauban in Quebec, Canada.

ESGold (CSE: ESAU) (OTCQB: ESAUF) announced a strategic leadership transition aligned with its push toward near-term gold and silver production at the Montauban Project in Quebec. As construction advances and the company executes its dual-track strategy—reprocessing historical tailings and district-scale exploration—ESGold is restructuring leadership to support the next phase of operational growth. The company is in advanced discussions with a senior executive to help drive this evolution and expects to share updates soon. Brad Kitchen will no longer serve as President, and ESGold has no plans to appoint a successor to the role at this time.

Scinai Immunotherapeutics (NASDAQ: SCNI) reported first quarter 2025 financial results, posting $586K in revenue, up from zero in the prior-year period, reflecting continued expansion of its CDMO business. R&D expenses declined to $1.3M from $1.6M, while marketing, general and administrative costs held steady at $500K. The company recorded a $1.6M net loss, improving from a $2.2M loss in Q1 2024, aided by reduced R&D and financial expenses. Cash and equivalents totaled $1M at quarter-end, down from $2M a year earlier.

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) has closed a US$1.008 million non-brokered private placement with major shareholder Hosken Consolidated Investments Limited (“HCI”) via its subsidiary Deepkloof Limited. The transaction, completed May 29, 2025, involved the issuance of 800,000 common shares at US$1.26 per share, restoring HCI’s ownership to 26%. Proceeds will support pre-construction and engineering work at the Waterberg Project in South Africa, along with general corporate purposes. As HCI is a related party, the deal qualifies for exemptions under MI 61-101 and was negotiated on an expedited basis.

Lantern Pharma (NASDAQ: LTRN) reported strong preclinical results for LP-184 in atypical teratoid rhabdoid tumors (“ATRT”), a rare and aggressive pediatric brain cancer. Presented by Dr. Eric Raabe of Johns Hopkins at the Society for Neuro-Oncology’s Pediatric Neuro-Oncology Conference, the data showed LP-184 significantly improved survival in two mouse models, with one model achieving a 345% increase in median survival (20 to 89 days, p<0.0001). LP-184 demonstrated potent anti-tumor activity across ATRT subtypes, high blood-brain barrier penetration, and a favorable safety profile. Lantern plans to launch a pediatric Phase I trial in late 2025 or early 2026, following the completion of its ongoing adult trial and pending consortium approvals. The findings reinforce LP-184’s potential as a novel therapy for ATRT, which is driven by SMARCB1 gene inactivation and currently lacks effective, low-toxicity treatments.

Crypto Ownership Reaches 24% in Major Markets, Report Says Crypto exchange firm Gemini has just published its 2025 Global State of Cryptocurrency Report, highlighting a steady rise in digital currency adoption across multiple regions. The report shows that more people in the United States, United Kingdom, Singapore, and France are getting involved with crypto. In 2024, about 21% of people in these countries owned some form of cryptocurrency. That number has grown to 24% in 2025.

Despite President Donald Trump’s loud opposition to renewable energy and any form of climate action, Republicans in Texas have embraced wind energy . The GOP president criticized America’s large investments in green energy during the Biden administration and has undone most of the former president’s climate-related policies since taking office.

Shopify, a top ecommerce platform used by many online businesses, has added new AI tools to make it easier for people to start, run, and grow their stores. These updates are part of a major release called “Editions,” and they are especially helpful for people who are not tech-savvy or don’t know how to code.

The marketing industry is undergoing a seismic transformation, driven by the rapid advancement of artificial intelligence (“AI”), machine learning and data analytics. Traditional strategies are no longer sufficient in a world where consumers expect hyperpersonalized content, real-time engagement and seamless user experiences. In this era of digital acceleration, companies must adapt or risk irrelevance. ONAR Holding Corp. (OTCQB: ONAR) is embracing this challenge head-on, positioning itself as a leader in the reinvention of marketing through proprietary technologies, global reach and a forward-thinking acquisition strategy designed to reshape how marketing services are delivered to growth-stage and mid-market companies.

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) has reached a global settlement agreement with former Executive Chairman and CEO Dr. Raza Bokhari, resolving all disputes originating from a 2021 proxy contest. Under the agreement, Bokhari will pay the company $2.35 million USD, bringing complete closure to multiple legal proceedings in both the U.S. and Canada and injecting non-dilutive capital into the business. The settlement, signed by Co-Chairmen Zeeshan Saeed and Anthony Durkacz, also bars future litigation between the parties. All parties deny any wrongdoing and affirm their actions were in the company’s best interest.

Texas could soon outlaw all THC products that are not medically prescribed. Last Wednesday, the Texas House passed Senate Bill 3 with a 95-44 vote, moving the state closer to banning the sale of non-medical THC items.

Tesla (NASDAQ: TSLA) is actively lobbying the U.S. Senate to retain key clean energy tax credits that are under threat from a House-passed reconciliation bill. The proposed legislation aims to roll back significant portions of the Inflation Reduction Act, including the 30% tax credits for residential solar installations and clean energy projects, which are currently set to expire in 2032. Tesla’s energy division, which reported a 67% year-over-year revenue increase to $2.7 billion in Q1 2025, heavily relies on these incentives. The company warns that abrupt termination of these credits could jeopardize America’s energy independence and hinder the deployment of over 60 gigawatts of clean energy capacity annually, essential for supporting AI and domestic manufacturing growth.

NVIDIA (NASDAQ: NVDA) is experiencing a stock surge, rising 5.3% on Thursday, even after issuing a cautious forecast for fiscal 2026. The company reported impressive revenue growth of 126% in fiscal 2024 and 114% in fiscal 2025, underscoring the robust demand for its AI and data center products. Analysts attribute the stock’s resilience to Nvidia’s pivotal role in the AI sector, with ongoing investments in data centers and AI infrastructure fueling optimism. Despite the tempered outlook, investors remain bullish on Nvidia’s long-term growth prospects in the evolving tech landscape.

Amazon.com (NASDAQ: AMZN) and The New York Times Co. (NYSE: NYT) have entered into a multi-year licensing agreement, marking the Times’ first venture into generative AI partnerships. Under this deal, Amazon will gain access to a range of NYT content—including articles from The New York Times, NYT Cooking, and The Athletic—for use in its AI products such as Alexa. The agreement permits Amazon to display summaries and excerpts of NYT content and utilize it to train its proprietary AI models. Financial terms of the deal were not disclosed. This collaboration comes amid a broader industry trend of media organizations licensing content to AI developers, following legal disputes over unauthorized data usage.

Snap (NYSE: SNAP) the parent company of Snapchat, is navigating a complex digital environment characterized by evolving user behaviors and intensified competition. The company reported a 9% year-over-year increase in daily active users, reaching 460 million in Q1 2025. Despite this growth, Snap’s market capitalization stands at $14 billion, with a current stock price of $8.38, suggesting potential undervaluation. Analysts highlight both opportunities and challenges as Snap endeavors to enhance its advertising strategies and product offerings to sustain growth and profitability.

Match Group (NASDAQ: MTCH) the parent company of popular dating platforms like Tinder and Hinge, is experiencing renewed investor interest following strategic realignments and positive analyst assessments. Despite a 3% year-over-year decline in total revenue for Q1 2025, the company reported an 18% earnings per share (EPS) beat, signaling improved operational efficiency. Analysts have adjusted their EPS estimates upward to $3.38 for the current year, reflecting a 13% increase from previous forecasts. The stock’s strong performance is further supported by a Zacks Rank of #1 (Strong Buy), indicating robust momentum and potential for continued growth.

Sprout Social (NASDAQ: SPT) a leading provider of cloud-based social media management solutions, has received a reiterated “Buy” rating from Needham analyst Scott Berg, with a maintained price target of $32.00. This endorsement follows a recent customer call featuring Caesars Entertainment, highlighting Sprout’s value proposition in managing complex brand portfolios through its advanced platform. Despite a 32% decline in stock value over the past six months, the company’s robust Q1 2025 performance, including a 13% year-over-year revenue increase to $109.3 million and a record non-GAAP operating margin of 11.5%, underscores its resilience and growth potential.

Roth Canada is pleased to announce its role as exclusive financial advisor to Tiny Ltd. (TSX.V: TINY) on the acquisition of a 66% interest in Serato Audio Research, a leading global audio software company. The transaction, valued at US$66 million plus contingent consideration, consisted of US$23.6 million in Tiny common shares and US$42.4 million in cash , implying a valuation of 3.2x annualized revenue and 9.6x adjusted EBITDA based on the nine months ended Sept. 30, 2024.

Brera Holdings (NASDAQ: BREA) announced a new advisory agreement with Toronto Blizzard Corp., Canada’s top soccer scholarship program, to launch an international grassroots development initiative for boys and girls. The program will integrate Blizzard’s academy system with Brera’s professional club network across Europe, Asia, and Africa—including Serie B’s SS Juve Stabia and North Macedonia’s Brera Strumica FC and Brera Tiverija FC—to create global pathways to the professional ranks for youth players. Soccer Hall of Famer and Blizzard owner Giuseppe “Joe” Parolini will serve as Brera’s Academy Sports Director, North America, as both organizations prepare for talent camps and international exchanges beginning in summer 2026.

Vivakor (NASDAQ: VIVK) reported financial results for the first quarter of 2025, highlighted by a 133% year-over-year revenue increase to $37.3 million and a 345% jump in gross profit to $4.8 million, driven largely by contributions from its recently acquired Endeavor Entities. Despite a net loss of $7.5 million due to $8.2 million in non-cash expenses, the company posted positive adjusted EBITDA of $319,000 and maintains strong momentum in its core logistics and terminaling businesses. CEO James Ballengee noted that 2025 is shaping up to be a record year as contracted assets reach peak revenue levels and expansion plans are underway to meet rising demand.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, is seeing momentum build on both the technical and commercial fronts, according to CEO Dr. Alan Baratz, who appeared on Fox Business’ The Claman Countdown to discuss the company’s progress ( https://ibn.fm/fVsGS ).

Telomir Pharmaceuticals (NASDAQ: TELO) announced positive preclinical results demonstrating that its oral therapeutic candidate, Telomir-1, restored vision and reversed retinal degeneration in a genetically modified zebrafish model of age-related macular degeneration (“AMD”). In a 14-day study, Telomir-1 improved central vision response, restored retinal architecture across multiple critical layers, reduced oxidative stress by up to 50%, and eliminated mortality observed in untreated animals. The treated zebrafish showed full recovery of visual function and structural regeneration, including in the inner nuclear and ganglion cell layers, underscoring Telomir-1’s potential as a regenerative treatment for AMD.

Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF) announced it will host a ground-breaking ceremony on May 29 for its Louisiana Strategic Metals Complex, the company’s first commercial rare earth element refining facility, located at England Airpark in Alexandria. The 80,800-square-foot site, secured under a long-term lease, will use Ucore’s RapidSX(TM) technology to produce high-purity rare earth oxides critical for electric vehicles, wind turbines and national defense applications. Supported by a US$18.4 million U.S. Department of Defense grant and a US$15+ million Louisiana incentive package, the project marks a key milestone in developing a secure domestic rare earth supply chain.

Standard Lithium (NYSE American: SLI), through its Smackover Lithium joint venture with Equinor, announced that the Arkansas Oil and Gas Commission has unanimously approved a 2.5% lithium royalty rate for the Reynolds Unit in Phase I of its South West Arkansas Project. This milestone marks the first state-approved royalty for lithium extracted from brine, establishing a precedent for future lithium projects in Arkansas. Combined with a $65.05 per acre annual brine fee, total compensation to brine owners will be approximately 3% based on current market prices. The project targets annual production of 22,500 tonnes of battery-grade lithium carbonate by 2028.

Emperor Metals (CSE: AUOZ) (OTCQB: EMAUF) (FRA:9NH) will participate in THE Mining Investment Event of the North, Canada’s premier Tier I mining conference, held June 3–5 in Québec City. Company management will be available for one-on-one investor meetings and will showcase core samples from its 2024 exploration programs at the Coreshack display during evening networking events. Emperor is currently advancing its Duquesne West Gold Project and recently acquired Lac Pelletier Project, which offers near-term production potential.

Quantum BioPharma (NASDAQ: QNTM) announced that portfolio company Unbuzzd Wellness Inc. (formerly Celly Nutrition Corp.), the developer of the scientifically backed unbuzzd(TM) beverage, has appointed MNP LLP to conduct PCAOB audits of its financials in preparation for a potential IPO. The appointment follows the resignation of Stern & Lovrics LLP and aligns with Unbuzzd’s February 2025 announcement of engaging a New York investment bank for capital raising and public listing advisory. The company also completed a formal name change to Unbuzzd Wellness Inc., effective May 23, 2025, with no impact on shareholder rights or share certificate validity.

SKYX Platforms (NASDAQ: SKYX) was spotlighted by PRISM MarketView after announcing it will deploy over 500,000 smart home devices in a $3 billion mixed-use development in Miami’s Little River District, where it will serve as the exclusive smart home infrastructure provider. The company also revealed its upcoming inclusion in the Russell 2000(R) and Russell 3000(R) Indexes, effective June 27, 2025, and recently reported record Q1 revenue of $20.1 million while reaffirming its outlook for second-half cash flow positivity.

Alzamend Neuro (NASDAQ: ALZN) is a clinical-stage biopharmaceutical company tackling some of the most pressing neurological and psychiatric conditions of our time — including Alzheimer’s disease, Bipolar Disorder (BD), Major Depressive Disorder (MDD), and Post-Traumatic Stress Disorder (PTSD). With a mission to “Make Alzheimer’s Just a Memory,” the Atlanta-based company is advancing a robust pipeline of therapies aimed at delivering long-overdue innovation in safety, efficacy, and tolerability. Rather than tweaking existing treatments, Alzamend is engineering bold new approaches that directly address the limitations of current standards of care.

The Trump administration has fulfilled one of the promises President Donald Trump made during his second presidential campaign: eliminating the federal tax credit for electric vehicle purchases . In a move that will undoubtedly have major repercussions for America’s nascent electric vehicle industry, the U.S. House has voted to eliminate federal EV tax credits. These credits of up to $7,500 were critical to boosting electric vehicle adoption in the country, and their loss will significantly affect battery electric vehicle (BEV) sales in the U.S.

The start of the week saw the price of gold surge by 4.8% to reach $3,358.13 as concerns among investors about the growing U.S. deficit and President Trump’s renewed threats of tariffs continued to fuel market uncertainty.

Texas’ Cancer Prevention & Research Institute has awarded $3 million to the University of Houston to establish a biomarker core for cancer immunotherapy. The research institute has earned a reputation for funding research projects which are groundbreaking. The $3m is a fraction of its $93m total package earmarked for awarding grants to entities within the state.

Tech company leaders are taking AI integration to a new level—not just in operations, but in how they represent themselves. Last week, some high-profile CEOs let their AI avatars handle parts of their companies’ earnings presentations, signaling a shift in how corporate communication is evolving.

I’m referring, of course, to the 90-day pause on new reciprocal tariffs that was suddenly announced by U.S. President Donald Trump on April 9. The tariffs that had been announced a week earlier, aimed at some 180 countries and territories around the globe as part of his administration’s desire to address the fentanyl crisis or balance trade deficits or finance tax cuts or bolster the domestic economy or punish remote, penguin-inhabited islands for ripping off America. Or something like that.

ECGI Holdings (OTC: ECGI) has launched Uplist Ventures, a new initiative focused on investing in overlooked, revenue-generating startups with long-term public market potential. Targeting pre-seed through Series B rounds—with a preference for Series A and B—Uplist Ventures will prioritize companies demonstrating solid fundamentals but bypassed by traditional venture firms seeking unsustainable growth. By leveraging ECGI’s public company status, the initiative offers a strategic path to liquidity, regulatory support, and operational guidance, transforming startups into future public entities aligned with shareholder value creation. Initial sector targets include AI, SaaS, healthcare tech, vertical software, and blockchain.

NANO Nuclear Energy (NASDAQ: NNE), has entered into a definitive securities purchase agreement with institutional investors for a private placement totaling $105 million, involving the sale of 3,888,889 shares of common stock at $27.00 per share. The financing includes participation from several prominent institutions, including a leading long-only mutual fund and a global investment manager. Expected to close on or about May 28, the offering would raise NANO Nuclear’s cash position to over $200 million, which the company plans to use to advance its micro nuclear reactor programs, support related energy ventures, pursue acquisitions, and drive toward initial revenue.

Mullen Automotive (NASDAQ: MULN) announced it will enact a 1-for-100 reverse stock split effective June 2, 2025, aiming to regain compliance with Nasdaq’s $1.00 minimum bid price requirement. Approved by shareholders on May 21 and finalized by the board, the reverse split will reduce Mullen’s outstanding common shares from approximately 80 million to about 800,000, with trading to begin on a split-adjusted basis under the same ticker symbol. No fractional shares will be issued, and all existing equity instruments and convertible securities will be proportionally adjusted, excluding the 2022 Equity Incentive Plan, which remains unchanged.

Fusion Fuel Green (Nasdaq: HTOO) announced that its subsidiary, BrightHy Solutions, has signed a strategic agency and partnership agreement with Sungrow Hydrogen to accelerate deployment of green hydrogen production technologies across Iberia. Under the agreement, BrightHy will act as agent for Sungrow Hydrogen’s electrolysis equipment, combining its regional engineering capabilities and market expertise with Sungrow’s cutting-edge innovations. The partnership builds on existing joint projects and aims to provide tailored, scalable hydrogen solutions for industrial and energy applications.

Alzamend Neuro (NASDAQ: ALZN) announced the first patient has been dosed in its Phase II clinical trial of AL001, a novel lithium-based therapeutic designed to treat Alzheimer’s, bipolar disorder, major depressive disorder and PTSD. Conducted at Massachusetts General Hospital, the study in healthy subjects will evaluate AL001’s ability to deliver lithium more efficiently to the brain while minimizing systemic side effects, potentially eliminating the need for therapeutic drug monitoring.

Cannabis Means Business, formerly CWCBEXPO, is proud to announce the New York Global Edition of its premiere business-to-business (“B2B”) cannabis conference. Scheduled for June 4-5 at the Javits Convention Center in New York City, this expo will offer attendees an opportunity to get hands-on with cannabis technology, hear from a fantastic line-up of speakers, network, and forge business deals with leading entrepreneurs in the space.

Bitcoin hit an all-time high in the past week, surpassing the record it set back in January. The digital asset surged to $109,760.08 before settling around $108,117, marking a 1.1% increase. This jump reflects a growing appetite for risk in the market, which had been shaken by last month’s tariff-driven dip.

Research from the Lawrence Berkeley National Laboratory in California has revealed that solar electricity is poised to become the most cost-efficient source of energy in South Korea . According to a research team based at the lab, solar has the potential to have the lowest levelized cost of energy (LCOE) of all energy sources in South Korea by 2030 to 2035. Solar energy is one of the most popular forms of renewable energy globally and is currently the third-largest source of renewable energy after hydropower and wind.

In a major decision for digital safety in Ireland, the High Court has turned down legal challenges from Reddit and Tumblr. Both platforms had tried to stop the country’s media authority from labeling them as video-sharing platform services (VSPS). However, the court ruled that the regulator acted within the law and made the right call.

Beeline Holdings (NASDAQ: BLNE) today announced the launch of MagicBlocks’ One-Click AI Sales Agent, a proprietary tool developed within and spun out of Beeline to enable mortgage lenders and brokers to instantly deploy intelligent, conversion-focused sales agents on their websites. The AI assistant is designed to activate in just two minutes, leveraging advanced NLP and behavioral science to engage visitors 24/7, qualify leads, and drive conversions — all without requiring technical expertise or development work.

ONAR (OTCQB: ONAR) CEO Claude Zdanow appeared on the latest episode of IBN’s TechMediaWire Podcast to discuss the company’s mission to help middle-market businesses generate revenue through AI-powered marketing solutions. Zdanow explained ONAR’s two main verticals—Storia, focused on digital marketing, and Of Kos, which serves B2B healthcare clients—and how both leverage advanced technology to drive client growth.

Lophora, a Danish biotech advancing next-generation psychedelic therapies, announced the first subjects have been dosed in its Phase 1 clinical trial of LPH-5, a novel serotonergic compound targeting central nervous system disorders. The trial, conducted by Biotrial in Rennes, France, is evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of both single and multiple ascending doses in healthy volunteers.

TransCode Therapeutics (NASDAQ: RNAZ), has appointed Dr. Phillip D. Zamore, a leading figure in RNA interference (RNAi) research and co-founder of Alnylam Pharmaceuticals, to its Scientific Advisory Board. Dr. Zamore, currently Chair of the RNA Therapeutics Institute at UMass Chan Medical School, is renowned for his foundational work in RNA biology and gene silencing mechanisms. His election to the National Academy of Sciences and other prestigious institutions underscores his impact on the field. TransCode leaders praised the addition as a strategic enhancement to the company’s RNA-targeted cancer therapy programs.

Bioadaptives (BDPT), through its premium pet wellness division PawPa(TM), announced compelling clinical results for its flagship product Regen(TM) Dog Chews, formulated to naturally stimulate stem cell release and support canine vitality, mobility, and comfort. In veterinarian-led trials, Regen demonstrated a 281.3% increase in circulating stem cells after four weeks. The product’s benefits are further measured using the company’s proprietary APBAR(R) rating system—modeled after the human APGAR score—helping pet owners track improvements in appearance, performance, behavior, attitude, and responsiveness. Crafted with all-natural ingredients including beneficial cyanobacteria and adaptogens, Regen(TM) is veterinarian-recommended, safe, and delivered in a tasty chew dogs love. With no reported adverse effects, Regen(TM) offers a daily, science-backed solution for pet wellness.

In an era where environmental sustainability has become a global priority, few industries face more scrutiny than oil and gas. As governments, consumers and investors demand cleaner practices and corporate accountability, companies are being urged to innovate and adapt—or risk falling behind. Vivakor (NASDAQ: VIVK), a vertically integrated energy infrastructure and environmental services company, has taken up this challenge with remarkable success. Focused on transportation, storage, reuse and remediation of oilfield fluids and waste, Vivakor is proving that environmental responsibility and profitability are not mutually exclusive.

With the launch of its newest shaft family, Newton Golf Company (NASDAQ: NWTG) is seeing triple-figure year-over-year revenue growth, according to the company’s latest financial numbers ( https://ibn.fm/hAQWB ). The company released its financial report for Q1 2025, noting that revenue had increased an impressive 246% during the first three months of the year.

Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) has appointed IBN to manage its corporate communications as the company advances its gold and silver projects in Nevada’s Walker Lane district. With four U.S.-based properties and a focus on unlocking oxide resource value from past-producing sites, Lahontan aims to transition toward near-term production through capital-efficient strategies. IBN will support this vision by deploying its expansive distribution network—spanning more than 5,000 outlets and 70+ brands—to boost visibility and engagement with investors, media, and the broader market.

The United States Senate has blocked a landmark California electric vehicle mandate that would have required the state to phase out gas-powered vehicles in favor of battery electric vehicles (BEVs). Although California already has the largest fleet of BEVs in the U.S ., the mandate aimed to accelerate electrification by pressuring carmakers to develop more EV models.

Gold ended this past week with strong gains as investors increasingly turned to safe-haven assets amid rising concerns about the reliability of the U.S. dollar. The uncertainty deepened after Moody’s downgraded America’s credit outlook, driving gold prices to $3,200 per ounce. As of the latest data, spot gold was trading at $3,361.2 per ounce.

On May 22, the U.S. House of Representatives approved the reconciliation bill for the 2025 budget with a one-vote difference between those in support of the bill and those opposed to it. The American Hospital Association says this legislation is going to have notable impacts upon healthcare insurance and Medicaid.

Klarna’s CEO and co-founder, Sebastian Siemiatkowski, has acknowledged that the company’s heavy reliance on AI for customer support hasn’t gone as planned. Speaking at the company’s headquarters in Stockholm, he admitted that cutting costs had been too much of a priority, leading to a drop in service quality.

TransCode Therapeutics (NASDAQ: RNAZ), has appointed Dr. Phillip D. Zamore, a leading figure in RNA interference (RNAi) research and co-founder of Alnylam Pharmaceuticals, to its Scientific Advisory Board. Dr. Zamore, currently Chair of the RNA Therapeutics Institute at UMass Chan Medical School, is renowned for his foundational work in RNA biology and gene silencing mechanisms. His election to the National Academy of Sciences and other prestigious institutions underscores his impact on the field. TransCode leaders praised the addition as a strategic enhancement to the company’s RNA-targeted cancer therapy programs.

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, is advancing its twin strategy of expanding a nationwide mental health clinic network while progressing toward FDA approval of its NMDA-based therapies for suicidal depression and bipolar disorder.

ONAR (OTCQB: ONAR), a marketing technology firm and agency network, will present at the Centurion One Capital 5th Annual LA Summit, set for June 5–6 at The Beverly Hills Hotel. Chairman and CEO Claude Zdanow is scheduled to speak at 1:50 p.m. PDT on June 6 and will also host one-on-one investor meetings. The event brings together top public and private companies with leading investors from North America and abroad. ONAR’s participation comes shortly after appointing Jon Bond to its board, adding momentum to the company’s evolving growth narrative.

Quantum BioPharma (NASDAQ: QNTM) has received human ethics review committee (HREC) approval in Australia to begin a Phase 2 clinical trial evaluating FSD202 for treating chronic widespread musculoskeletal nociplastic pain associated with idiopathic Mast Cell Activation Syndrome (MCAS). The randomized, double-blind, placebo-controlled trial will enroll 60 patients and measure pain reduction over 56 days. FSD202, based on ultra-micronized palmitoylethanolamide (PEA), targets inflammation-related conditions and may offer a new therapeutic option for MCAS, a debilitating disorder with no current cure. Executives from Quantum BioPharma emphasized the urgent need for safe alternatives and expressed readiness to advance clinical development.

Brera Holdings (NASDAQ: BREA) announced that its affiliated Scottish club, Caledonia Braves, claimed the 2025 Fenix Trophy title with a 3-1 win over two-time champions FC United of Manchester. The final took place earlier this month at Lake Iseo, Italy, during the fourth edition of the tournament, which has earned recognition from UEFA and is dubbed the “Champions League for amateurs” by BBC Sport. Organized by Brera’s Milan-based club, Brera FC, the FENIX Trophy unites 16 non-professional clubs from across Europe in a celebration of sporting culture, community impact, and innovative football models.

McEwen Mining (NYSE: MUX) (TSX: MUX) extends congratulations to Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF) on mobilizing its largest drill program to date at the 100%-owned Golddigger Property in British Columbia’s prolific Golden Triangle. The 2025 campaign will consist of 40,000 meters of drilling focused entirely on the Surebet high-grade gold discovery, targeting expansion of the mineralized system laterally and at depth, and testing multiple feeder dykes and structural intersections.

ESGold (CSE: ESAU) (OTCQB: ESAUF), a fully permitted pre-production resource company focused on clean mining innovation, was featured in a recent Investorideas.com snapshot highlighting Canadian gold companies advancing amid rising gold prices. ESGold reported the successful delivery of its Humphrey spiral concentrators to the Montauban site in Quebec, completing the gravity separation circuit required for gold and silver recovery from historic tailings. The circuit, designed for up to 1,000 TPD throughput, is a cornerstone of the company’s low-impact tailings-to-cash flow model. CEO Paul Mastantuono emphasized the significance of this milestone, noting construction is progressing on schedule with first production still targeted for year-end 2025. ESGold is also preparing an updated PEA and plans to release a 3D geological model in the coming weeks. The company’s progress was presented alongside strong Q1 2025 results from Canadian peers including Barrick Gold, Kinross Gold, and B2Gold, as Canada solidifies its position as the fourth-largest gold-producing nation globally.

NanoViricides, Inc. (NYSE American: NNVC) announced it will present at the BIO International Convention 2025 in Boston on Monday, June 16 at 2:30 p.m. ET. Dr. Anil R. Diwan, President and Executive Chairman, will provide updates on the company’s drug pipeline and licensing-ready platform technologies. The presentation will focus on NV-387, a broad-spectrum antiviral nearing Phase II trials for MPOX and demonstrating superior preclinical efficacy against RSV, Influenza A and coronaviruses. With the potential to become the first empiric antiviral therapy, NV-387 aims to revolutionize viral treatment similarly to how antibiotics transformed bacterial care. NanoViricides will also showcase additional candidates targeting herpesviruses and HIV, as well as its proprietary nanoviricide platform, which enables oral delivery, drug rescue, and tissue-specific targeting. Dr. Diwan will be available for meetings via BIO Partnering from June 16 to 19.

Ecuador is on the verge of a mine-building surge, as President Daniel Noboa’s reelection coincides with high metals prices and a handful of projects ready for development.

Newton Golf Company (NASDAQ: NWTG) announced it has regained compliance with Nasdaq Listing Rule 5550(b)(1) after reporting $6.2 million in stockholders’ equity in its Q1 2025 10-Q filing. The Nasdaq confirmation closes a compliance matter originally raised in April. Executive Chairman Greg Campbell credited the resolution to the company’s financial strength and growing market traction. Newton Golf posted 246% year-over-year revenue growth in Q1 2025, with gross margins reaching 70%, driven by rising adoption of its Newton Motion shaft across retail channels and pro tours. Now used by over 40 professional players, the brand continues to expand globally and reinforce its innovation credentials within the performance golf segment.